All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
Catch up with our live Twitter coverage from the Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® 2023
Visual abstract | Vitamin A for the prevention of GvHD in pediatric patients undergoing allo-HSCT
Here, we present data from a trial evaluating the efficacy of high-dose vitamin A in preventing GvHD in pediatric patients undergoing allo-HSCT...
Orca-T in patients undergoing allo-HSCT for hematologic malignancies
In this article, we report recent data from two trials on Orca-T in the treatment of patients with hematologic malignancies, both in the matched and 7/8 mismatched donor setting.
Subscribe to get the best content related to GvHD delivered to your inbox